Medical & Hospital Equipment
EOSCARE IMMUNOASSAY ANALYZER
Brand: SUPER-BIO
Time-resolved Fluorescence Immunoassay Analyzer
Time-resolved Fluorescence Immunoassay Analyzer is a rapid, quantitative instrument. It tests quantitave items like cardiac markers inflammation, hormone, diabetes, etc.
> Ultra high sensitivity
> Self-Calibration
> Android system
> LIS/HIS connectivity
It’s ground-breaking, thorough, and essential for quantitative exams. It is an autonomous in-vitro diagnostic equipment that quantitatively evaluates the concentration of analytes in blood or other samples.
Sensitive
TRFIA is a time-resolved fluorescence immunoassay that combines extended decay lifetime markers with time-resolved fluorescence to effectively remove non-specific fluorescence interference while also considerably boosting analytical sensitivity.
Dosage
<p>It’s ground-breaking, thorough, and essential for quantitative exams. It is an autonomous in-vitro diagnostic equipment that quantitatively evaluates the concentration of analytes in blood or other samples.</p><h3>Sensitive</h3><p>TRFIA is a time-resolved fluorescence immunoassay that combines extended decay lifetime markers with time-resolved fluorescence to effectively remove non-specific fluorescence interference while also considerably boosting analytical sensitivity.</p>
Directions for use
<p>.</p><p>Establish assay critical success factors (i.e. sensitivity required).</p><p>2.</p><p>Ensure appropriate antibody and antigen reagents are available.</p><p>3.</p><p>Adsorb antigen or capture antibody to a solid surface.</p><p>4.</p><p>Wash off unbound reagents.</p><p>5.</p><p>Block nonspecific binding sites to reduce background.</p><p>6.</p><p>Incubate the secondary antibody with the sample.</p><p>7.</p><p>Wash off unbound reagents.</p><p>8.</p><p>Incubate secondary antibody-conjugate with sample.</p><p>9.</p><p>Wash off unbound reagents.</p><p>10.</p><p>Incubate substrate to generate signal.</p><p>11.</p><p>Calibration curve fitting, data analysis and quantitation by non-linear regression.</p><p>Develop and validate a method for incubation of compounds with a relevant target in the screening mode.</p><p>6.</p><p>Develop a sample collection procedure from screening experiments.</p><p>7.</p><p>Develop data analysis procedures to use immunoassay data to derive compound potency such as IC50 or EC50.</p>